Celcuity Inc.
CELC- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001603454
Insider trades, last 90 days
0 buys · 1 sell
- Sold $317.75M
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
302
- +10 vs. Q1 2026
- Total value $7.03B
Superinvestors holding CELC
1
- At the end of Q2 2026
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by CELC insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 20265:42 PM ET | Jul 14, 2026 | BAKER JULIAN and 3 othersOther: Former 10% owner | SSaleCommon Stock | −3.1M | $102.50 | −$317.75M | 4.37M | −41.5% | SEC |
| May 6, 2026 | May 4, 2026 | Buller Richard EDirector | SSaleCommon Stock | −9K | $140.4664 | −$1.26M | 6.76K | −57.1% | SEC10b5-1 |
| May 6, 2026 | May 4, 2026 | Dalvey DavidDirector | SSaleCommon Stock | −25K | $140.68 | −$3.52M | 65K | −27.8% | SEC10b5-1 |
| Apr 2, 2026 | Mar 31, 2026 | Buller Richard EDirector | SSaleCommon Stock | −3K | $110.272 | −$330.82K | 6.76K | −30.7% | SEC10b5-1 |
| Jan 29, 2026 | Jan 27, 2026 | Dalvey DavidDirector | SSaleCommon Stock | −20K | $120.03 | −$2.4M | 90K | −18.2% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in CELC at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 7,915,792 | $897.31M | 4.50% | −30,750,000−79.5% | Reduced |
| Avoro Capital Advisors LLC | 3,400,000 | $355.71M | 3.19% | +25,000+0.7% | Added |
| Linden Advisors LP | – | $352.52M | 1.83% | – | – |
| PERCEPTIVE ADVISORS LLC | 3,197,200 | $349.12M | 5.42% | +70,000+2.2% | Added |
| RTW INVESTMENTS, LP | 3,304,903 | $345.76M | 2.95% | +265,282+8.7% | Added |